Ferring Pharmaceuticals (Switzerland)

Ferring Pharmaceuticals (Switzerland)

Ferring Pharmaceuticals is a Swiss multinational biopharmaceutical company specialising in areas such as reproductive health, maternal health, gastroenterology and urology. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Ferring Pharmaceuticals (Switzerland), Switzerland, covering academic research published from 2000 to 2022. Read More.


Open Access Percentage

59%


Total
Publications

915


Total Open
Publications

538


Total
Citations

19K


Open Access
Percentage

59%


Total
Publications

915


Total Open
Publications

538


Total
Citations

19K

Wikipedia

Website

download

Breakdown

32% 22% 5% 41%

Publisher Open

32%

Both

22%

Other Platform Open

5%

Closed

41%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01020304050607080Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Open

Closed

Publisher Open

20%OA Journal

OA Journal 20%

100

Hybrid 54%

262

No Guarantees 26%

128

Other Platform Open

Domain 82%

199

Institution 32%

77

Other Internet 11%

27

Public 7%

18

Preprint 5%

11

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
202
Europe PMC
Domain
113
Semantic Scholar
Public
14
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
9
KTH Royal Institute of Technology - KTH Publication Database DiVA
Other Internet
8
Technischen Universität Darmstadt
Institution
7
University of Copenhagen - Research at the University of Copenhagen
Institution
6
Research Square
Preprint
6
Lund University - Lund University Publications
Institution
6
Ghent University - Ghent University Academic Bibliography
Institution
6
1 / 8

Data updated 3 October 2023

Share

Share

Share